Revenue ($USD) : $2,300,000,000
R&D spend : not available
Employees : 9,478
Fiscal year end : 12/31/2023
CEO : Carl Cook

www.cookmedical.com

Cook Medical in July 2024 announced that it signed a letter of intent to sell its Reproductive Health business (Cook ART) to private equity firm Astorg. Cook Medical entered into this agreement nearly one year after a previous attempt to sell off these businesses to Cooper Cos. failed amid FTC scrutiny. Cook was able to sell select assets to Cooper for $300 million in late 2023. –CN